Bisson Barcelona joins fight against Lou Gehrig’s disease

BARRINGTON, N.H. — The ALS Therapy Alliance, a research group dedicated to developing effective therapies for a disorder that is best known as Lou Gehrig’s disease, is again partnering with local public relations firm Bisson Barcelona.

“Bisson Barcelona has been instrumental in the implementation of the campaign,” said Alan Abraham, director of the ALS Therapy Alliance. “This fund-raising effort has been a massive undertaking and we would not have the support of CVS/pharmacy if it wasn’t for their team’s leadership, direction and enthusiasm for the project. There is a definite chemistry.”

The ALS Therapy Alliance was founded in 2000 to provide a vehicle for a diverse group of scientists and clinicians to share and coordinate studies related to amyotrophic lateral sclerosis, or ALS. While little is known about the cause of or possible treatments for ALS, the disease, which affects the nervous system and eventually leads to muscle deterioration, it is best recognized for its affect on Baseball Hall of Famer Lou Gehrig.

For the last six years, the ALS Therapy Alliance has united with CVS/pharmacy in a fund-raising campaign to enhance and enable ALS research. By asking CVS/pharmacy customers for a donation, the partnership has raised nearly $8 million thus far. The ALS Therapy Alliance has been structured to ensure that 100 percent of the proceeds generated by this endeavor are committed to ALS studies.

Bisson Barcelona, a Barrington, N.H., publicity firm that focuses on image management and media placement, has worked with this team of professionals since the second year of the campaign’s implementation. In this capacity, the publicity company writes promotional materials and press releases, facilitates the design and creation of public relations information and implements the overall campaign.

For information about ALS, visit the ALS Association’s Web site at www.alsa.org. For information about Bisson Barcelona, visit www.bissonbarcelona.com